This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
This article is within the scope of WikiProject Chemicals, a daughter project of WikiProject Chemistry, which aims to improve Wikipedia's coverage of chemicals. To participate, help improve this article or visit the project page for details on the project.ChemicalsWikipedia:WikiProject ChemicalsTemplate:WikiProject Chemicalschemicals articles
This article has been given a rating which conflicts with the project-independent quality rating in the banner shell. Please resolve this conflict if possible.
The article lists Cefotaxime as not being active against Pseudomonas spp.
I found this rather odd, as most literature online indicates susceptibility to Cefotaxime (with MIC ranges similar to that of Ceftazidime). It may not be used as often as ceftazidime, cefepime, anti-pseudomonal penicillins or carbapenems, but research suggests it does have anti-pseudomonal activity. Lack of use does not indicate lack of efficacy; gentamicin also has anti-pseudomonal coverage, but hardly ever used.
Could anyone correct me if I'm wrong here? — Preceding unsigned comment added by 50.40.213.4 (talk) 11:56, 9 November 2015 (UTC)[reply]